These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6833272)

  • 1. An estrogen receptor model to describe the regulation of prolactin synthesis by antiestrogens in vitro.
    Lieberman ME; Gorski J; Jordan VC
    J Biol Chem; 1983 Apr; 258(8):4741-5. PubMed ID: 6833272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogens in vitro.
    Lieberman ME; Jordan VC; Fritsch M; Santos MA; Gorski J
    J Biol Chem; 1983 Apr; 258(8):4734-40. PubMed ID: 6833271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure.
    Jordan VC; Lieberman ME
    Mol Pharmacol; 1984 Sep; 26(2):279-85. PubMed ID: 6541293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
    Borgna JL; Scali J
    Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitro.
    Jordan VC; Lieberman ME; Cormier E; Koch R; Bagley JR; Ruenitz PC
    Mol Pharmacol; 1984 Sep; 26(2):272-8. PubMed ID: 6482874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS; Parker CJ; McCague R; Jordan VC
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geometric isomers of substituted triphenylethylenes and antiestrogen action.
    Jordan VC; Haldemann B; Allen KE
    Endocrinology; 1981 Apr; 108(4):1353-61. PubMed ID: 6781873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivatives of estradiol and estrone.
    Jordan VC; Koch R
    Endocrinology; 1989 Apr; 124(4):1717-26. PubMed ID: 2924721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
    Jordan VC; Gosden B
    J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
    Jordan VC; Gosden B
    Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth.
    Chun TY; Gregg D; Sarkar DK; Gorski J
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2325-30. PubMed ID: 9482884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen agonistic and antagonistic action of 8 non-steroidal antiestrogens on progestin receptor induction in rat pituitary gland and uterus.
    Kirchhoff J; Grünke W; Hoffmann B; Nagel W; Ghraf R
    Brain Res; 1983 Dec; 289(1-2):380-4. PubMed ID: 6661654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogen action in the medial basal hypothalamus and pituitary of immature female rats: insights concerning relationships among estrogen, dopamine, and prolactin.
    Toney TW; Katzenellenbogen BS
    Endocrinology; 1986 Dec; 119(6):2661-9. PubMed ID: 3780547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand interaction at the estrogen receptor to program antiestrogen action: a study with nonsteroidal compounds in vitro.
    Jordan VC; Koch R; Langan S; McCague R
    Endocrinology; 1988 Apr; 122(4):1449-54. PubMed ID: 3345720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogens are partial estrogen agonists for prolactin production in primary pituitary cultures.
    Martinez-Campos A; Amara JF; Dannies PS
    Mol Cell Endocrinol; 1986 Dec; 48(2-3):127-33. PubMed ID: 3803705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory models of breast cancer to aid the elucidation of antiestrogen action.
    Jordan VC
    J Lab Clin Med; 1987 Mar; 109(3):267-77. PubMed ID: 3102656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site.
    Murphy LC; Sutherland RL
    J Clin Endocrinol Metab; 1983 Aug; 57(2):373-9. PubMed ID: 6408114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activities of thioether derivatives related to the antiestrogens tamoxifen and ICI 164384.
    Auger S; Mérand Y; Pelletier JD; Poirier D; Labrie F
    J Steroid Biochem Mol Biol; 1995 Jun; 52(6):547-65. PubMed ID: 7779759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitro.
    Jordan VC; Koch R; Mittal S; Schneider MR
    Br J Pharmacol; 1986 Jan; 87(1):217-23. PubMed ID: 3955300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.